Aminoguanidine bicarbonate, with the chemical formula CH6N4CO3 and CAS number 2582-30-1, is a compound of interest for its various applications in pharmaceuticals and research. The purpose of this article is to introduce aminoguanidine bicarbonate products and clarify their uses and significance.
Aminoguanidine bicarbonate is a derivative of guanidine, a naturally occurring compound in plants and microorganisms. It is a white crystalline powder that is easily soluble in water, making it easy to use in a variety of formulations. This compound has attracted interest for its potential pharmacological properties and its role in research and development.
One of the main uses of aminoguanidine bicarbonate is in the pharmaceutical field. It has been studied for its potential as an anti-glycation agent, meaning it may help prevent or slow down the formation of advanced glycation end products (AGE) in the body. AGEs are associated with various age-related diseases, such as diabetes, atherosclerosis, and neurodegenerative diseases. By inhibiting the formation of AGEs, aminoguanidine bicarbonate shows promise in developing drugs to treat these diseases.
Additionally, aminoguanidine bicarbonate cas 2582-30-1 has been studied for its potential role in the treatment of diabetic complications. Diabetes can lead to various complications such as diabetic nephropathy, retinopathy, and neuropathy, and aminoguanidine bicarbonate has shown potential to alleviate these complications through its antiglycation and antioxidant properties. Research in this area shows that the compound is able to reduce oxidative stress and prevent protein cross-linking, a key factor in diabetes complications.
In addition to pharmaceutical applications, aminoguanidine bicarbonate is used in research settings. It is used in research related to oxidative stress, inflammation and age-related diseases. The compound's ability to modulate nitric oxide production and its anti-inflammatory properties make it a valuable tool for understanding the mechanisms underlying various diseases and developing potential therapeutic interventions.
It is important to note that although aminoguanidine bicarbonate shows promise in various fields, further research and clinical trials are needed to fully understand its efficacy and safety. As with any pharmaceutical compound, thorough evaluation and testing is critical before widespread use for therapeutic purposes.
In summary, aminoguanidine bicarbonate, with CAS number 2582-30-1, is a compound with potential in pharmaceutical and research fields. Its anti-glycation, antioxidant and anti-inflammatory properties make it a candidate for research into developing drugs against age-related diseases and complications of diabetes. As research continues in this area, aminoguanidine bicarbonate may provide new avenues for the management of various health conditions, paving the way for potential therapeutic advances.
Post time: May-30-2024